List of Tables
Table 1. Global Formulated Methyldiethanolamine (MDEA) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Formulated Methyldiethanolamine (MDEA) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Formulated Methyldiethanolamine (MDEA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Formulated Methyldiethanolamine (MDEA) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Formulated Methyldiethanolamine (MDEA) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Formulated Methyldiethanolamine (MDEA) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Formulated Methyldiethanolamine (MDEA) Sales by Region (2020-2025) & (Tons)
Table 8. Global Formulated Methyldiethanolamine (MDEA) Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Formulated Methyldiethanolamine (MDEA) Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Formulated Methyldiethanolamine (MDEA) Production by Region (2020-2025) & (Tons)
Table 12. Global Formulated Methyldiethanolamine (MDEA) Production by Region (2026-2031) & (Tons)
Table 13. Global Formulated Methyldiethanolamine (MDEA) Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Formulated Methyldiethanolamine (MDEA) Sales Share by Manufacturers (2020-2025)
Table 15. Global Formulated Methyldiethanolamine (MDEA) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Formulated Methyldiethanolamine (MDEA) Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Formulated Methyldiethanolamine (MDEA) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Formulated Methyldiethanolamine (MDEA) as of 2024)
Table 19. Global Formulated Methyldiethanolamine (MDEA) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Formulated Methyldiethanolamine (MDEA) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Formulated Methyldiethanolamine (MDEA) Manufacturing Base and Headquarters
Table 22. Global Formulated Methyldiethanolamine (MDEA) Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Formulated Methyldiethanolamine (MDEA) Sales by Type (2020-2025) & (Tons)
Table 26. Global Formulated Methyldiethanolamine (MDEA) Sales by Type (2026-2031) & (Tons)
Table 27. Global Formulated Methyldiethanolamine (MDEA) Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Formulated Methyldiethanolamine (MDEA) Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Formulated Methyldiethanolamine (MDEA) ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Formulated Methyldiethanolamine (MDEA) Sales by Application (2020-2025) & (Tons)
Table 32. Global Formulated Methyldiethanolamine (MDEA) Sales by Application (2026-2031) & (Tons)
Table 33. Formulated Methyldiethanolamine (MDEA) High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Formulated Methyldiethanolamine (MDEA) Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Formulated Methyldiethanolamine (MDEA) Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Formulated Methyldiethanolamine (MDEA) ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Formulated Methyldiethanolamine (MDEA) Growth Accelerators and Market Barriers
Table 40. North America Formulated Methyldiethanolamine (MDEA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Formulated Methyldiethanolamine (MDEA) Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Formulated Methyldiethanolamine (MDEA) Growth Accelerators and Market Barriers
Table 43. Europe Formulated Methyldiethanolamine (MDEA) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Formulated Methyldiethanolamine (MDEA) Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Growth Accelerators and Market Barriers
Table 48. Southeast Asia Formulated Methyldiethanolamine (MDEA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Formulated Methyldiethanolamine (MDEA) Investment Opportunities and Key Challenges
Table 50. Central and South America Formulated Methyldiethanolamine (MDEA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Formulated Methyldiethanolamine (MDEA) Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Formulated Methyldiethanolamine (MDEA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. BASF Corporation Information
Table 54. BASF Description and Major Businesses
Table 55. BASF Product Models, Descriptions and Specifications
Table 56. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. BASF Sales Value Proportion by Product in 2024
Table 58. BASF Sales Value Proportion by Application in 2024
Table 59. BASF Sales Value Proportion by Geographic Area in 2024
Table 60. BASF Formulated Methyldiethanolamine (MDEA) SWOT Analysis
Table 61. BASF Recent Developments
Table 62. Dow Corporation Information
Table 63. Dow Description and Major Businesses
Table 64. Dow Product Models, Descriptions and Specifications
Table 65. Dow Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Dow Sales Value Proportion by Product in 2024
Table 67. Dow Sales Value Proportion by Application in 2024
Table 68. Dow Sales Value Proportion by Geographic Area in 2024
Table 69. Dow Formulated Methyldiethanolamine (MDEA) SWOT Analysis
Table 70. Dow Recent Developments
Table 71. INEOS Group Corporation Information
Table 72. INEOS Group Description and Major Businesses
Table 73. INEOS Group Product Models, Descriptions and Specifications
Table 74. INEOS Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. INEOS Group Sales Value Proportion by Product in 2024
Table 76. INEOS Group Sales Value Proportion by Application in 2024
Table 77. INEOS Group Sales Value Proportion by Geographic Area in 2024
Table 78. INEOS Group Formulated Methyldiethanolamine (MDEA) SWOT Analysis
Table 79. INEOS Group Recent Developments
Table 80. Huntsman Corporation Information
Table 81. Huntsman Description and Major Businesses
Table 82. Huntsman Product Models, Descriptions and Specifications
Table 83. Huntsman Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Huntsman Sales Value Proportion by Product in 2024
Table 85. Huntsman Sales Value Proportion by Application in 2024
Table 86. Huntsman Sales Value Proportion by Geographic Area in 2024
Table 87. Huntsman Formulated Methyldiethanolamine (MDEA) SWOT Analysis
Table 88. Huntsman Recent Developments
Table 89. Sintez OKA Group Corporation Information
Table 90. Sintez OKA Group Description and Major Businesses
Table 91. Sintez OKA Group Product Models, Descriptions and Specifications
Table 92. Sintez OKA Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Sintez OKA Group Sales Value Proportion by Product in 2024
Table 94. Sintez OKA Group Sales Value Proportion by Application in 2024
Table 95. Sintez OKA Group Sales Value Proportion by Geographic Area in 2024
Table 96. Sintez OKA Group Formulated Methyldiethanolamine (MDEA) SWOT Analysis
Table 97. Sintez OKA Group Recent Developments
Table 98. Evonik Industries Corporation Information
Table 99. Evonik Industries Description and Major Businesses
Table 100. Evonik Industries Product Models, Descriptions and Specifications
Table 101. Evonik Industries Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Evonik Industries Recent Developments
Table 103. Axens Corporation Information
Table 104. Axens Description and Major Businesses
Table 105. Axens Product Models, Descriptions and Specifications
Table 106. Axens Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Axens Recent Developments
Table 108. Solvay Corporation Information
Table 109. Solvay Description and Major Businesses
Table 110. Solvay Product Models, Descriptions and Specifications
Table 111. Solvay Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Solvay Recent Developments
Table 113. Advance Petrochemicals Corporation Information
Table 114. Advance Petrochemicals Description and Major Businesses
Table 115. Advance Petrochemicals Product Models, Descriptions and Specifications
Table 116. Advance Petrochemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Advance Petrochemicals Recent Developments
Table 118. Maoming Yunlong Industrial Development Corporation Information
Table 119. Maoming Yunlong Industrial Development Description and Major Businesses
Table 120. Maoming Yunlong Industrial Development Product Models, Descriptions and Specifications
Table 121. Maoming Yunlong Industrial Development Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Maoming Yunlong Industrial Development Recent Developments
Table 123. Jiangsu Taihu New Materials Corporation Information
Table 124. Jiangsu Taihu New Materials Description and Major Businesses
Table 125. Jiangsu Taihu New Materials Product Models, Descriptions and Specifications
Table 126. Jiangsu Taihu New Materials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. Jiangsu Taihu New Materials Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Formulated Methyldiethanolamine (MDEA) Product Picture
Figure 2. Global Formulated Methyldiethanolamine (MDEA) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity: 95% Product Picture
Figure 4. Purity: 97% Product Picture
Figure 5. Purity: 99% Product Picture
Figure 6. Others Product Picture
Figure 7. Global Formulated Methyldiethanolamine (MDEA) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Gas Desulfurization
Figure 9. Natural Gas Processing
Figure 10. Oil Refining
Figure 11. Syngas Production
Figure 12. Others
Figure 13. Formulated Methyldiethanolamine (MDEA) Report Years Considered
Figure 14. Global Formulated Methyldiethanolamine (MDEA) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 16. Global Formulated Methyldiethanolamine (MDEA) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Formulated Methyldiethanolamine (MDEA) Revenue Market Share by Region (2020-2031)
Figure 18. Global Formulated Methyldiethanolamine (MDEA) Sales (2020-2031) & (Tons)
Figure 19. Global Formulated Methyldiethanolamine (MDEA) Sales (CAGR) by Region (2020-2031) (Tons)
Figure 20. Global Formulated Methyldiethanolamine (MDEA) Sales Market Share by Region (2020-2031)
Figure 21. Global Formulated Methyldiethanolamine (MDEA) Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 22. Global Formulated Methyldiethanolamine (MDEA) Production Trend by Region (2020-2031) (Tons)
Figure 23. Global Formulated Methyldiethanolamine (MDEA) Production Market Share by Region (2020-2031)
Figure 24. Production Capacity Enablers & Constraints
Figure 25. Formulated Methyldiethanolamine (MDEA) Production Growth Rate in North America (2020-2031) & (Tons)
Figure 26. Formulated Methyldiethanolamine (MDEA) Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 27. Formulated Methyldiethanolamine (MDEA) Production Growth Rate in China (2020-2031) & (Tons)
Figure 28. Formulated Methyldiethanolamine (MDEA) Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 29. Top 5 and Top 10 Manufacturers Formulated Methyldiethanolamine (MDEA) Sales Volume Market Share in 2024
Figure 30. Global Formulated Methyldiethanolamine (MDEA) Revenue Market Share Ranking (2024)
Figure 31. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 32. Purity: 95% Revenue Market Share by Manufacturer in 2024
Figure 33. Purity: 97% Revenue Market Share by Manufacturer in 2024
Figure 34. Purity: 99% Revenue Market Share by Manufacturer in 2024
Figure 35. Others Revenue Market Share by Manufacturer in 2024
Figure 36. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 37. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 38. Global Formulated Methyldiethanolamine (MDEA) Sales Market Share by Type (2020-2031)
Figure 39. Global Formulated Methyldiethanolamine (MDEA) Revenue Market Share by Type (2020-2031)
Figure 40. Global Formulated Methyldiethanolamine (MDEA) Sales Market Share by Application (2020-2031)
Figure 41. Global Formulated Methyldiethanolamine (MDEA) Revenue Market Share by Application (2020-2031)
Figure 42. North America Formulated Methyldiethanolamine (MDEA) Sales YoY (2020-2031) & (Tons)
Figure 43. North America Formulated Methyldiethanolamine (MDEA) Revenue YoY (2020-2031) & (US$ Million)
Figure 44. North America Top 5 Manufacturers Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) in 2024
Figure 45. North America Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Type (2020- 2031)
Figure 46. North America Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 47. North America Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Application (2020-2031)
Figure 48. North America Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. US Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 50. Canada Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 51. Mexico Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 52. Europe Formulated Methyldiethanolamine (MDEA) Sales YoY (2020-2031) & (Tons)
Figure 53. Europe Formulated Methyldiethanolamine (MDEA) Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Europe Top 5 Manufacturers Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) in 2024
Figure 55. Europe Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Type (2020-2031)
Figure 56. Europe Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 57. Europe Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Application (2020-2031)
Figure 58. Europe Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Germany Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 60. France Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 61. U.K. Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 62. Italy Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 63. Russia Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Sales YoY (2020-2031) & (Tons)
Figure 65. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Asia-Pacific Top 8 Manufacturers Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) in 2024
Figure 67. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Type (2020- 2031)
Figure 68. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 69. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Application (2020-2031)
Figure 70. Asia-Pacific Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Indonesia Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 72. Japan Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 73. South Korea Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 74. China Taiwan Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 75. India Formulated Methyldiethanolamine (MDEA) Revenue (2020-2031) & (US$ Million)
Figure 76. Central and South America Formulated Methyldiethanolamine (MDEA) Sales YoY (2020-2031) & (Tons)
Figure 77. Central and South America Formulated Methyldiethanolamine (MDEA) Revenue YoY (2020-2031) & (US$ Million)
Figure 78. Central and South America Top 5 Manufacturers Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) in 2024
Figure 79. Central and South America Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Type (2021-2031)
Figure 80. Central and South America Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 81. Central and South America Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Application (2020-2031)
Figure 82. Central and South America Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 83. Brazil Formulated Methyldiethanolamine (MDEA) Revenue (2020-2025) & (US$ Million)
Figure 84. Argentina Formulated Methyldiethanolamine (MDEA) Revenue (2020-2025) & (US$ Million)
Figure 85. Middle East, and Africa Formulated Methyldiethanolamine (MDEA) Sales YoY (2020-2031) & (Tons)
Figure 86. Middle East and Africa Formulated Methyldiethanolamine (MDEA) Revenue YoY (2020-2031) & (US$ Million)
Figure 87. Middle East and Africa Top 5 Manufacturers Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) in 2024
Figure 88. Middle East and Africa Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Type (2021-2031)
Figure 89. South America Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 90. Middle East and Africa Formulated Methyldiethanolamine (MDEA) Sales Volume (Tons) by Application (2020-2031)
Figure 91. Middle East and Africa Formulated Methyldiethanolamine (MDEA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 92. GCC Countries Formulated Methyldiethanolamine (MDEA) Revenue (2020-2025) & (US$ Million)
Figure 93. Turkey Formulated Methyldiethanolamine (MDEA) Revenue (2020-2025) & (US$ Million)
Figure 94. Egypt Formulated Methyldiethanolamine (MDEA) Revenue (2020-2025) & (US$ Million)
Figure 95. South Africa Formulated Methyldiethanolamine (MDEA) Revenue (2020-2025) & (US$ Million)
Figure 96. Formulated Methyldiethanolamine (MDEA) Industry Chain Mapping
Figure 97. Regional Formulated Methyldiethanolamine (MDEA) Manufacturing Base Distribution (%)
Figure 98. Formulated Methyldiethanolamine (MDEA) Production Process
Figure 99. Regional Formulated Methyldiethanolamine (MDEA) Production Cost Structure
Figure 100. Channels of Distribution (Direct Vs Distribution)
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed